AFT Pharmaceuticals Limited

NZSE:AFT Stock Report

Market Cap: NZ$317.7m

AFT Pharmaceuticals Past Earnings Performance

Past criteria checks 5/6

AFT Pharmaceuticals has been growing earnings at an average annual rate of 20.3%, while the Pharmaceuticals industry saw earnings growing at 35.6% annually. Revenues have been growing at an average rate of 15.5% per year. AFT Pharmaceuticals's return on equity is 17.8%, and it has net margins of 8%.

Key information

20.3%

Earnings growth rate

20.7%

EPS growth rate

Pharmaceuticals Industry Growth35.6%
Revenue growth rate15.5%
Return on equity17.8%
Net Margin8.0%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

May 25
AFT Pharmaceuticals Limited (NZSE:AFT) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

May 22
Does AFT Pharmaceuticals (NZSE:AFT) Deserve A Spot On Your Watchlist?

Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Oct 17
Is Now The Time To Put AFT Pharmaceuticals (NZSE:AFT) On Your Watchlist?

Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

May 23
Should You Be Adding AFT Pharmaceuticals (NZSE:AFT) To Your Watchlist Today?

Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

Dec 01
Is AFT Pharmaceuticals Limited (NZSE:AFT) Trading At A 50% Discount?

We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

Jul 30
We Discuss Whether AFT Pharmaceuticals Limited's (NZSE:AFT) CEO Is Due For A Pay Rise

With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Jun 02
With AFT Pharmaceuticals Limited (NZSE:AFT) It Looks Like You'll Get What You Pay For

Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

Mar 20
Should You Be Impressed By AFT Pharmaceuticals Limited's (NZSE:AFT) ROE?

A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Feb 13
A Quick Analysis On AFT Pharmaceuticals' (NZSE:AFT) CEO Compensation

Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Jan 23
Are AFT Pharmaceuticals's (NZSE:AFT) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Jan 02
Does AFT Pharmaceuticals (NZSE:AFT) Have A Healthy Balance Sheet?

Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

Dec 12
Should AFT Pharmaceuticals (NZSE:AFT) Be Disappointed With Their 89% Profit?

AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 21
AFT Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Revenue & Expenses Breakdown

How AFT Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NZSE:AFT Revenue, expenses and earnings (NZD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2419516586
31 Dec 2318513576
30 Sep 2317511565
30 Jun 2316611534
31 Mar 2315711494
31 Dec 2214914464
30 Sep 2214117424
30 Jun 2213518404
31 Mar 2213020384
31 Dec 2112515383
30 Sep 2112011393
30 Jun 211169382
31 Mar 211138372
31 Dec 201105361
30 Sep 201073360
30 Jun 201077370
31 Mar 2010612370
31 Dec 1910011360
30 Sep 199411351
30 Jun 19894351
31 Mar 1985-3351
31 Dec 1884-7382
30 Sep 1883-11404
30 Jun 1882-12395
31 Mar 1881-14397
31 Dec 1779-14378
30 Sep 1776-143410
30 Jun 1773-163410
31 Mar 1769-18349
31 Dec 1667-18338
30 Sep 1664-18328
30 Jun 1664-16307
31 Mar 1664-13296
31 Dec 1563-13275
30 Sep 1562-13264
30 Jun 1559-13254
31 Mar 1556-13245
31 Mar 1449-1162

Quality Earnings: AFT has high quality earnings.

Growing Profit Margin: AFT's current net profit margins (8%) are higher than last year (6.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AFT has become profitable over the past 5 years, growing earnings by 20.3% per year.

Accelerating Growth: AFT's earnings growth over the past year (46.5%) exceeds its 5-year average (20.3% per year).

Earnings vs Industry: AFT earnings growth over the past year (46.5%) exceeded the Pharmaceuticals industry 28.2%.


Return on Equity

High ROE: AFT's Return on Equity (17.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.